Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

1 Feb 2024 07:00

RNS Number : 6024B
Barr(A.G.) PLC
01 February 2024
 

IMMEDIATE RELEASE 1 February 2024

A.G. BARR p.l.c.

("A.G. BARR" or "the Group")

Trading Update

 

A.G. BARR p.l.c., the branded multi-beverage business with a portfolio of market-leading UK brands, including IRN-BRU, Rubicon, FUNKIN and Boost.

 

Strong revenue and profit performance - positive business momentum

We are pleased to report an anticipated strong revenue and profit performance in respect of the full year ended 28 January 2024.

52 weeks ended28 January 2024

52 weeks ended29 January 2023

Growth

Group revenue

c.£400m

£317.6m

c.26%

 

Revenue is expected to be c.£400m, representing c.26% year-on-year growth and c.7.6% on a like-for-like basis, excluding the contribution from the Boost Drinks business acquired in December 2022. 

Adjusted profit before tax1 is now expected to be c.£49.5m, up 13.8% on the prior year (2022/23 : £43.5m) and slightly ahead of previous market expectations.

Despite the wet summer weather which impacted Q3 market conditions, our positive underlying brand momentum ensured a strong H2 Group performance :

? Soft Drinks - including IRN-BRU, Rubicon and Boost

Inflation in the wider soft drinks market continued to drive value growth but impacted volumes within the sector. However, our brand building and pricing strategy delivered both value and volume growth, ensuring we continue to offer consumers great tasting and affordable brands.

? FUNKIN Cocktails

Delivered a strong Q4 particularly in the off trade through an excellent performance in the ready to drink segment. While the on trade channel remains variable, with late night venues experiencing reduced footfall, reports of improved festive trading for a range of hospitality venues is encouraging as we look forward.

? MOMA Foods  

Further double-digit sales growth, supported by new business wins, most notably within the speciality coffee channel.

We continue to experience cost inflation albeit at a less significant level than in the prior year. Our supply chain capital investment programme is on track supporting the in-sourcing of the Boost and Rio brands. The associated operational leverage and synergy benefits are supporting the acceleration of our margin rebuild programme.

Roger White, Chief Executive, commented :

"All our teams across the Group have worked hard to deliver an excellent overall performance. This has been supported by continued brand investment, strong execution of our sales plans and progress across our supply chain improvement programme. We have positive momentum behind our brands and business as we enter the new financial year.

This strong trading performance, coupled with the benefits already being delivered by our margin rebuild programme, has ensured we close the year with a strong profit performance and confidence in the Group's long-term growth strategy."

For more information, please contact :

A.G. BARR Instinctif Partners

0330 390 3900 020 7457 2010/05

Roger White, Chief Executive Justine Warren

Stuart Lorimer, Finance Director Matthew Smallwood

Next update : Full Year Results - 26 March 2024

 

Note 1 : Reported profit before tax is currently expected to be c.£50.3m reflecting the release of a £0.8m prior year accrual associated with the acquisition earn-out of Boost Drinks Limited in December 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTWPURAGUPCGMG
Date   Source Headline
3rd Jun 20267:00 amRNS-RLaunch of IRN-BRU Summer Campaign
27th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20261:30 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSResult of AGM
11th May 20262:46 pmRNSDirector/PDMR Shareholding
21st Apr 202610:43 amRNSAnnual Report and Accounts and Notice of AGM
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
13th Apr 20269:39 amRNSDirector/PDMR Shareholding
7th Apr 202611:21 amRNSDirector/PDMR Shareholding
1st Apr 20268:44 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSFinal Results
23rd Mar 20267:00 amRNS-RLaunch of IRN-BRU 'ZERO'
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSNotice of Results Presentation
9th Feb 20263:56 pmRNSDirector/PDMR Shareholding
4th Feb 20264:16 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSFull Year Trading Update
15th Jan 20267:00 amRNSDirectorate change
12th Jan 202611:00 amRNSDirector/PDMR Shareholding
8th Dec 20252:49 pmRNSDirector/PDMR Shareholding
19th Nov 20251:44 pmRNSHolding(s) in Company
17th Nov 20253:25 pmRNSDirector/PDMR Shareholding
10th Nov 20254:44 pmRNSDirector/PDMR Shareholding
10th Nov 20254:38 pmRNSDirector/PDMR Shareholding
8th Oct 20252:39 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSInterim Results
11th Sep 20252:00 pmRNSNotice of Results
10th Sep 20256:00 pmRNSDirector/PDMR Shareholding
28th Aug 20252:00 pmRNS2025 Annual General Meeting Update
12th Aug 20254:01 pmRNSDirector/PDMR Shareholding
1st Aug 20257:01 amRNSDirector Declaration
29th Jul 20257:00 amRNSTrading Statement
9th Jul 202511:00 amRNSAppointment of Non-Executive Director
8th Jul 20252:02 pmRNSDirector/PDMR Shareholding
3rd Jul 202511:09 amRNSDirector/PDMR Shareholding
11th Jun 202511:01 amRNSDirector/PDMR Shareholding
10th Jun 20254:20 pmRNSDirector/PDMR Shareholding
10th Jun 20252:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSCapital Markets Event
23rd May 20255:36 pmRNSResult of AGM
12th May 20251:54 pmRNSDirector/PDMR Shareholding
30th Apr 20259:15 amRNSPotential disposal of Strathmore Business
28th Apr 20253:16 pmRNSDirector/PDMR Shareholding
28th Apr 20253:15 pmRNSDirector/PDMR Shareholding
22nd Apr 202510:24 amRNSAnnual Financial Report
9th Apr 202511:23 amRNSDirector/PDMR Shareholding
8th Apr 20253:29 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSResults for year ended 25 January 2025
10th Mar 20252:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.